GlassScriptPhysician profile
Kenyon Anderson
NPI 1043280555
$5,734.89
in general payments reported to CMS, 2019-2025
11 companies · $1,159 in 2025
The $1,159 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $260 · 2021: $378 · 2022: $424 · 2023: $2,765 · 2024: $350 · 2025: $1,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,385 · Food and Beverage: $1,568 · Entertainment: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,384.80 |
| Food and Beverage | $1,567.79 |
| Entertainment | $320.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,840.33 | 2019-2025 | Cvi Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $1,279.00 | 2019-2025 | Acuvue |
| Optos, INC. | $818.37 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $255.85 | 2024-2025 | Infuse |
| Alcon Vision LLC | $132.29 | 2023-2025 | Precision 1, Precision7, Dailies |
| Ivantis, INC | $125.00 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $113.37 | 2020 | |
| Biotissue Holdings INC. | $102.78 | 2023-2025 | |
| Abbvie INC. | $28.96 | 2025 | |
| Abb Con-Cise Optical Group LLC | $20.61 | 2019 | |
| Mallinckrodt Hospital Products INC. | $18.33 | 2025 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenyon Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.